A single study indicates that in an FTD cohort [69], GRN mutation carriers had higher levels of NfL and lower p/t-tau ratios than patients with the C9ORF72 mutation, MAPT mutation, or no known mutation. This evidence concerns the gene TBXT and frontotemporal dementia.